-
1
-
-
22144432283
-
A systematic review of the prevalence of schizophrenia
-
Saha S., Chant D., Welham J., McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med 2005, 2:e141.
-
(2005)
PLoS Med
, vol.2
-
-
Saha, S.1
Chant, D.2
Welham, J.3
McGrath, J.4
-
2
-
-
0031417026
-
Treatment-resistant schizophrenia: the role of clozapine
-
Meltzer H.Y. Treatment-resistant schizophrenia: the role of clozapine. Curr Med Res Opin 1997, 14:1-20.
-
(1997)
Curr Med Res Opin
, vol.14
, pp. 1-20
-
-
Meltzer, H.Y.1
-
3
-
-
0032073383
-
The natural history and pathophysiology of treatment resistant schizophrenia
-
Sheitman B.B., Lieberman J.A. The natural history and pathophysiology of treatment resistant schizophrenia. J Psychiatr Res 1998, 2:143-150.
-
(1998)
J Psychiatr Res
, vol.2
, pp. 143-150
-
-
Sheitman, B.B.1
Lieberman, J.A.2
-
4
-
-
0023812652
-
Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine
-
Kane J., Honigfeld G., Singer J., Meltzer H. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988, 45:789-796.
-
(1988)
Arch Gen Psychiatry
, vol.45
, pp. 789-796
-
-
Kane, J.1
Honigfeld, G.2
Singer, J.3
Meltzer, H.4
-
5
-
-
0025633831
-
Defining treatment refractoriness in schizophrenia
-
Brenner H.D., Dencker S.J., Goldstein M.J., Hubbard J.W., Keegan D.L., Kruger G., Kulhanek F., et al. Defining treatment refractoriness in schizophrenia. Schizophr Bull 1990, 16:551-565.
-
(1990)
Schizophr Bull
, vol.16
, pp. 551-565
-
-
Brenner, H.D.1
Dencker, S.J.2
Goldstein, M.J.3
Hubbard, J.W.4
Keegan, D.L.5
Kruger, G.6
Kulhanek, F.7
-
6
-
-
0029896051
-
Proper psychosocial rehabilitation for stabilised patients with schizophrenia: the role of new therapies
-
Peuskens J. Proper psychosocial rehabilitation for stabilised patients with schizophrenia: the role of new therapies. Eur Neuropsychopharmacol 1996, 6:S7-12.
-
(1996)
Eur Neuropsychopharmacol
, vol.6
-
-
Peuskens, J.1
-
7
-
-
0035666578
-
The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches
-
Lieberman J.A., Perkins D., Belger A., Chakos M., Jarskog F., Boteva K., Gilmore J. The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry 2001, 50:884-897.
-
(2001)
Biol Psychiatry
, vol.50
, pp. 884-897
-
-
Lieberman, J.A.1
Perkins, D.2
Belger, A.3
Chakos, M.4
Jarskog, F.5
Boteva, K.6
Gilmore, J.7
-
8
-
-
33845651345
-
Remission in first-episode psychosis: predictor variables and symptom improvement patterns
-
Emsley R., Oosthuizen P.P., Kidd M., Koen L., Niehaus D.J., Turner H.J. Remission in first-episode psychosis: predictor variables and symptom improvement patterns. J Clin Psychiatry 2006, 67:1707-1712.
-
(2006)
J Clin Psychiatry
, vol.67
, pp. 1707-1712
-
-
Emsley, R.1
Oosthuizen, P.P.2
Kidd, M.3
Koen, L.4
Niehaus, D.J.5
Turner, H.J.6
-
9
-
-
0032852650
-
Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course?
-
McGlashan T.H. Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course?. Biol Psychiatry 1999, 46:899-907.
-
(1999)
Biol Psychiatry
, vol.46
, pp. 899-907
-
-
McGlashan, T.H.1
-
11
-
-
14844334624
-
Remission in schizophrenia: proposed criteria and rationale for consensus
-
Andreasen N.C., Carpenter W.T., Kane J.M., Lasser R.A., Marder S.R., Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005, 162:441-449.
-
(2005)
Am J Psychiatry
, vol.162
, pp. 441-449
-
-
Andreasen, N.C.1
Carpenter, W.T.2
Kane, J.M.3
Lasser, R.A.4
Marder, S.R.5
Weinberger, D.R.6
-
12
-
-
0035667156
-
Management of treatment resistance in schizophrenia
-
Conley R.R., Kelly D.R. Management of treatment resistance in schizophrenia. Biol Psychiatry 2001, 50:898-911.
-
(2001)
Biol Psychiatry
, vol.50
, pp. 898-911
-
-
Conley, R.R.1
Kelly, D.R.2
-
13
-
-
0000187287
-
Treatment-resistant schizophrenia
-
Blackwell Science Ltd., Oxford, S.R. Hirsch (Ed.)
-
Schultz S.C. Treatment-resistant schizophrenia. Schizophrenia 1995, 484-496. Blackwell Science Ltd., Oxford. S.R. Hirsch (Ed.).
-
(1995)
Schizophrenia
, pp. 484-496
-
-
Schultz, S.C.1
-
15
-
-
0018865788
-
Parenteral loxapine in severely disturbed schizophrenic patients
-
Deniker P., Loo H., Cottereau M.J. Parenteral loxapine in severely disturbed schizophrenic patients. J Clin Psychiatry 1980, 41:23-26.
-
(1980)
J Clin Psychiatry
, vol.41
, pp. 23-26
-
-
Deniker, P.1
Loo, H.2
Cottereau, M.J.3
-
16
-
-
0033017831
-
The evolving definition of Treatment Resistance
-
Peuskens J. The evolving definition of Treatment Resistance. J Clin Psychiatry 1999, 60:4-8.
-
(1999)
J Clin Psychiatry
, vol.60
, pp. 4-8
-
-
Peuskens, J.1
-
17
-
-
0027178496
-
Psychopharmacologic treatment of schizophrenia
-
Kane J., Marder S.R. Psychopharmacologic treatment of schizophrenia. Schizophr Bull 1993, 19:287-302.
-
(1993)
Schizophr Bull
, vol.19
, pp. 287-302
-
-
Kane, J.1
Marder, S.R.2
-
18
-
-
0027452203
-
Treatment of neuroleptic-resistant schizophrenic relapse
-
Kinon J., Kane J., Johns C., Perovich R., Ismi M., Koreen A., Weiden P. Treatment of neuroleptic-resistant schizophrenic relapse. Psychopharmacol Bull 1993, 29:309-314.
-
(1993)
Psychopharmacol Bull
, vol.29
, pp. 309-314
-
-
Kinon, J.1
Kane, J.2
Johns, C.3
Perovich, R.4
Ismi, M.5
Koreen, A.6
Weiden, P.7
-
19
-
-
0029989771
-
Pharmacological treatment strategies in the non-responsive schizophrenic patient
-
Barnes T.R., McEvedy C.J. Pharmacological treatment strategies in the non-responsive schizophrenic patient. Int Clin Psychopharmacol 1996, 11:67-71.
-
(1996)
Int Clin Psychopharmacol
, vol.11
, pp. 67-71
-
-
Barnes, T.R.1
McEvedy, C.J.2
-
20
-
-
0026718710
-
Positron emission tomographic analysis of central D1 and D2 dopamine receptors occupancy in patient treated with classical neuroleptic and clozapine: relation to extrapyramidal side effects
-
Fabre L.F., Nordström A.L., Wiesel F.A., Pauli S., Halldin C., Sedvall G. Positron emission tomographic analysis of central D1 and D2 dopamine receptors occupancy in patient treated with classical neuroleptic and clozapine: relation to extrapyramidal side effects. Arch Gen Psychiatry 1992, 49:538-544.
-
(1992)
Arch Gen Psychiatry
, vol.49
, pp. 538-544
-
-
Fabre, L.F.1
Nordström, A.L.2
Wiesel, F.A.3
Pauli, S.4
Halldin, C.5
Sedvall, G.6
-
21
-
-
0029114174
-
Effects of stringent criteria on eligibility for clozapine among public mental health clients
-
Juarez-Reyes M.G., Shumway M., Battle C., Bacchetti P., Hansen M.S., Hargreaves W.A. Effects of stringent criteria on eligibility for clozapine among public mental health clients. Psychiatr Serv 1995, 46:801-806.
-
(1995)
Psychiatr Serv
, vol.46
, pp. 801-806
-
-
Juarez-Reyes, M.G.1
Shumway, M.2
Battle, C.3
Bacchetti, P.4
Hansen, M.S.5
Hargreaves, W.A.6
-
22
-
-
0019414614
-
A follow-up study of the results of five forms of treatment
-
May P.R., Tuma A.H., Dixon W.J., Yale C., Thiele D.A., Kraude W.H., Schizophrenia A follow-up study of the results of five forms of treatment. Arch Gen Psychiatry 1981, 38:776-784.
-
(1981)
Arch Gen Psychiatry
, vol.38
, pp. 776-784
-
-
May, P.R.1
Tuma, A.H.2
Dixon, W.J.3
Yale, C.4
Thiele, D.A.5
Kraude, W.H.6
Schizophrenia7
-
23
-
-
0026796022
-
Treatment of the neuroleptic-nonresponsive schizophrenic patient
-
Meltzer H.Y. Treatment of the neuroleptic-nonresponsive schizophrenic patient. Schizophr Bull 1992, 18:515-542.
-
(1992)
Schizophr Bull
, vol.18
, pp. 515-542
-
-
Meltzer, H.Y.1
-
24
-
-
0026517979
-
Dimensions of outcome with clozapine
-
Meltzer H.Y. Dimensions of outcome with clozapine. Br J Psychiatry 1992, 160:46-53.
-
(1992)
Br J Psychiatry
, vol.160
, pp. 46-53
-
-
Meltzer, H.Y.1
-
26
-
-
0003174188
-
Practice guideline for the treatment of patients with schizophrenia
-
American Psychiatric Association
-
Practice guideline for the treatment of patients with schizophrenia. Am J Psychiatry 1997, 154:1-63. American Psychiatric Association.
-
(1997)
Am J Psychiatry
, vol.154
, pp. 1-63
-
-
-
27
-
-
2842615828
-
Estudio crítico de la influencia de los síntomas negativos en la respuesta terapeútica de la esquizofrenia
-
Acuña M.J., Martin J., Noval D., Blanco M. Estudio crítico de la influencia de los síntomas negativos en la respuesta terapeútica de la esquizofrenia. Actas Luso Esp Neurol Psiquiatr Cienc Afines 1998, 26:209-213.
-
(1998)
Actas Luso Esp Neurol Psiquiatr Cienc Afines
, vol.26
, pp. 209-213
-
-
Acuña, M.J.1
Martin, J.2
Noval, D.3
Blanco, M.4
-
28
-
-
0027414570
-
Negative symptoms and emotional blunting in schizophrenic patients
-
De Leon J., Peralta V., Cuesta M. Negative symptoms and emotional blunting in schizophrenic patients. J Clin Psychiatry 1993, 54:103-108.
-
(1993)
J Clin Psychiatry
, vol.54
, pp. 103-108
-
-
De Leon, J.1
Peralta, V.2
Cuesta, M.3
-
29
-
-
0018899460
-
Molecular pathology of schizophrenia: more than one disease process?
-
Crow T.J. Molecular pathology of schizophrenia: more than one disease process?. Br Med J 1980, 280:66-68.
-
(1980)
Br Med J
, vol.280
, pp. 66-68
-
-
Crow, T.J.1
-
32
-
-
0021877999
-
Negative symptoms in schizophrenia: their longitudinal course and prognostic importance
-
Pogue-Geile M.F., Harrow M. Negative symptoms in schizophrenia: their longitudinal course and prognostic importance. Am J Psychiatry 1985, 11:427-439.
-
(1985)
Am J Psychiatry
, vol.11
, pp. 427-439
-
-
Pogue-Geile, M.F.1
Harrow, M.2
-
33
-
-
0023883767
-
Deficit and nondeficit forms of schizophrenia: the concept
-
Carpenter W.T. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 1988, 145:578-583.
-
(1988)
Am J Psychiatry
, vol.145
, pp. 578-583
-
-
Carpenter, W.T.1
-
34
-
-
0027944883
-
An empirical analysis of latent structures underlying schizophrenic symptoms: a four-syndrome model
-
Peralta V., Cuesta M., De Leon J. An empirical analysis of latent structures underlying schizophrenic symptoms: a four-syndrome model. Biol Psychiatry 1994, 36:726-736.
-
(1994)
Biol Psychiatry
, vol.36
, pp. 726-736
-
-
Peralta, V.1
Cuesta, M.2
De Leon, J.3
-
35
-
-
47249104675
-
The evolution of drug development in schizophrenia: past issues and future opportunities
-
Carpenter W.T., Koenig J.I. The evolution of drug development in schizophrenia: past issues and future opportunities. Neuropsychopharmacology 2008, 33:2061-2079.
-
(2008)
Neuropsychopharmacology
, vol.33
, pp. 2061-2079
-
-
Carpenter, W.T.1
Koenig, J.I.2
-
36
-
-
34147214251
-
Adjunctive treatment with risperidone in clozapine-resistant schizophrenia: A case report review
-
Lerma-Carrillo I., Molina J.D., Cuevas-Durán T., González-Parra S., Blasco-Fontecilla H., Andrade-Rosa C., López-Muñoz F., et al. Adjunctive treatment with risperidone in clozapine-resistant schizophrenia: A case report review. Clin Neuropharmacol 2007, 30:114-121.
-
(2007)
Clin Neuropharmacol
, vol.30
, pp. 114-121
-
-
Lerma-Carrillo, I.1
Molina, J.D.2
Cuevas-Durán, T.3
González-Parra, S.4
Blasco-Fontecilla, H.5
Andrade-Rosa, C.6
López-Muñoz, F.7
-
38
-
-
85012092311
-
Early intervention in psychosis. The critical period hypothesis
-
Birchwood M., Todd P., Jackson C. Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry 1998, 172:53-59.
-
(1998)
Br J Psychiatry
, vol.172
, pp. 53-59
-
-
Birchwood, M.1
Todd, P.2
Jackson, C.3
-
39
-
-
0027972344
-
Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia
-
Breier A., Buchanan R.W., Kirkpatrick B., Davis O.R., Irish D., Summerfelt A., Carpenter W.T. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. Am J Psychiatry 1994, 151:20-26.
-
(1994)
Am J Psychiatry
, vol.151
, pp. 20-26
-
-
Breier, A.1
Buchanan, R.W.2
Kirkpatrick, B.3
Davis, O.R.4
Irish, D.5
Summerfelt, A.6
Carpenter, W.T.7
|